AQR Capital Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $116K | Sell |
37,702
-10,468
| -22% | -$32.3K | ﹤0.01% | 3151 |
|
|
2025
Q1 | $168K | Sell |
48,170
-554
| -1% | -$1.93K | ﹤0.01% | 2923 |
|
|
2024
Q4 | $159K | Buy |
48,724
+15,006
| +45% | +$49.1K | ﹤0.01% | 2709 |
|
|
2024
Q3 | $130K | Buy |
+33,718
| New | +$130K | ﹤0.01% | 2627 |
|
|
2023
Q4 | – | Sell |
-40,598
| Closed | -$82.4K | – | 2322 |
|
|
2023
Q3 | $82.4K | Buy |
40,598
+26,075
| +180% | +$52.9K | ﹤0.01% | 2249 |
|
|
2023
Q2 | $33.4K | Sell |
14,523
-6,412
| -31% | -$14.7K | ﹤0.01% | 2170 |
|
|
2023
Q1 | $63.4K | Sell |
20,935
-1,818
| -8% | -$5.51K | ﹤0.01% | 2134 |
|
|
2022
Q4 | $53K | Sell |
22,753
-69
| -0.3% | -$161 | ﹤0.01% | 2168 |
|
|
2022
Q3 | $44K | Buy |
22,822
+3,392
| +17% | +$6.54K | ﹤0.01% | 2152 |
|
|
2022
Q2 | $53K | Buy |
+19,430
| New | +$53K | ﹤0.01% | 2131 |
|
|
2021
Q3 | – | Sell |
-19,036
| Closed | -$58K | – | 2236 |
|
|
2021
Q2 | $58K | Buy |
+19,036
| New | +$58K | ﹤0.01% | 2207 |
|
|
2019
Q2 | – | Sell |
-28,128
| Closed | -$101K | – | 2053 |
|
|
2019
Q1 | $101K | Sell |
28,128
-93,514
| -77% | -$336K | ﹤0.01% | 2131 |
|
|
2018
Q4 | $466K | Buy |
121,642
+75,066
| +161% | +$288K | ﹤0.01% | 1808 |
|
|
2018
Q3 | $440K | Buy |
46,576
+27,354
| +142% | +$258K | ﹤0.01% | 1991 |
|
|
2018
Q2 | $140K | Buy |
+19,222
| New | +$140K | ﹤0.01% | 2267 |
|